Objectives Herbal and dietary supplements (HDS) can cause adverse effects or interact with diseases and medications. Community pharmacists have a role in ensuring the safe use of HDS, but they have been reported to not being proactive in providing pharmacist care (PCare) for HDS users. The reasons for this warranted investigation. The study aimed to explore pharmacists' understanding of PCare for HDS users, and to investigate the underlying beliefs or factors influencing its provision by community pharmacists, guided by the theory of planned behaviour. Methods A qualitative study using a semi-structured interview guide was conducted in a purposive sample of community pharmacists working in Bangkok, Thailand, from December 2016 to June 2017. All interviews were audio-recorded, transcribed and analysed using qualitative content analysis. Key findings Twenty-two pharmacists were interviewed. Several professional pharmacy activities were regarded as PCare for HDS users. The pharmacists reported that the provision of such care was advantageous in terms of promoting rational use of HDS, ensuring safety of users, enhancing own knowledge and promote customers' loyalty. Facilitators for PCare included the initiation of conversation about HDS by the users, professional training and the availability of reference materials. The reluctance of HDS users to accept pharmacists' opinions, insufficient education in HDS and limited sources of information were identified as barriers. Most pharmacists believed that PCare for HDS users is part of their responsibilities. Conclusions The pharmacists expressed their views on the meaning of PCare for HDS users, and described the beliefs and factors that facilitate or impede its provision. Information from this study can be used to inform strategies that can promote pharmacists to become more proactive in providing PCare for HDS users.
Introduction
Herbal and dietary supplements (HDS) have been commonly perceived as effective, and safe. [1] Many individuals use HDS to prevent or treat diseases, or enhance the effects of conventional therapies. [2] The use of HDS is generally driven by the motivation to have more control over one's health. [3] Although some HDS have been shown to be effective in certain health conditions, [4] many of the products lack clinical evidence. [5] Moreover, the use of HDS can also bring about a number of complications that can be the cause for emergency department visits and hospitalisations. [6] The use of HDS is common in many countries, including the United States, Australia, Denmark, Germany, and South Korea. [7] In Thailand, based on the purpose for which the HDS are intended, and the availability of evidences for safety, efficacy, and quality, the products can be classified as 'food' or 'medicine' by the Thai Food and Drug Administration. [8] These products are predominantly available over the counter in community pharmacies in Thailand. [9] In a survey by Tangkiatkumjai et al., the prevalence of HDS use among the Thai general population was 52%. [10] Of these HDS users, 58.4% consumed herbal medicines to treat illnesses, whereas 65.3% made use of dietary supplements to enhance their well-being. Moreover, the consumption of HDS was also reported to be common in Thai patients with chronic diseases who were also using modern medicines. [2, 3] This pattern of consumption poses a potential problem because prescribed medicines may interact with the HDS, and thus may cause treatment failure or toxicity. [11] Additionally, patients with chronic diseases are not likely to disclose their HDS consumption to the healthcare providers and therefore, HDS-drug or HDSdisease interactions, together with the resultant adverse effects, may go unnoticed. [2, 12] Since community pharmacies are the main providers of HDS for the public, community pharmacists can have a vital role in ensuring the safe use of HDS. [13] A few systematic reviews indicated that although pharmacists generally have positive attitudes towards their role in providing pharmacist care (PCare) for HDS users, their engagement in the PCare activities was found to be low. [13, 14] In particular, pharmacists seldom assess the needs of HDS use among users, monitor the efficacy and safety of HDS, or communicate with the users about their HDS use. There is a paucity of information as to why pharmacists were not proactive in providing PCare for HDS users, warranting further investigation.
The theory of planned behaviour (TPB) has been shown to be useful in predicting the behavioural intentions and actual behaviours of healthcare professionals including the pharmacists. [15] Compared to the other decision-making models, the TPB also highlights social influences on behavioural performance. Previous studies showed that the social influences are essential determinants for pharmacists' intentions to perform various pharmacist activities. [16, 17] The TPB therefore is considered a useful theoretical framework for the present study. To date, there is a lack of study that utilises the TPB to uncover beliefs and factors influencing the provision of PCare for HDS users. Additionally, previous studies were mainly focused on the attitudes of pharmacists towards the HDS in general, and rarely put emphasis on the behaviour of providing PCare for HDS users. This study was therefore aimed to explore the understanding about PCare for HDS users, and to investigate the beliefs and factors underlying the behaviour among a sample of Thai community pharmacists. In order to gain insights into the pharmacists' beliefs, and other internal and external factors, a qualitative rather than quantitative exploration was adopted.
Methods
The qualitative study was approved by the Research Ethics Review Committee for Research Involving Human Research Participants at Chulalongkorn University (COA: 189/2016). Findings of the study were reported in accordance with the consolidated criteria for reporting qualitative research checklist (Appendix S1). [18] The study was conducted in Bangkok, Thailand, from December 2016 to June 2017. HDS refers to products containing plant-derived materials, or containing dietary ingredients e.g., vitamins, minerals, amino acids and substances such as enzymes, organ tissues, glands, metabolites, extracts and concentrates in the form of pills, capsules, tablets, powder or liquids that are taken to treat and/or prevent diseases or maintain health. [19, 20] In this study, all professional activities carried out by pharmacists when dealing with HDS users e.g., the collection of HDS users' medication and medical history, and the provision of counselling were referred to as 'pharmacist care'. This definition was chosen to avoid confusion with the term 'pharmaceutical care' that concerns on the optimisation of medication use. [21] Moreover in Thailand, pharmaceutical care has been frequently associated with activities such as advice about medicines, home medical care, and lifestyle modification, and rarely incorporate the aspects of HDS use. [22] The term PCare has been used in previous published studies. [23] Study design A face-to-face semi-structured interview was used to elicit pharmacists' beliefs about PCare for HDS users. For this study, an extended TPB framework was adopted ( Figure 1 ). The framework proposes that the intention to provide PCare for HDS users is the antecedent to its actual provision. The intention is fundamentally predicted by three determinants i.e., attitudes, subjective norms and perceived behavioural control. [24] Attitudes refer to the pharmacists' overall evaluation of the behaviour (the provision of PCare for HDS users), which includes the advantages and drawbacks of the behaviour performance. Subjective norms relate to the pharmacists' feeling of social pressure from significant people to perform the behaviour. Perceived behavioural control is the perceived ability of pharmacists to perform the target behaviour. Three salient beliefs i.e., behavioural, normative and control beliefs are the underlying factors that influence attitudes, subjective norms and perceived behavioural control respectively. Apart from the original constructs of the TPB framework, a construct for the professional norm was included as this element has been shown to be an important determinant for pharmacists' intention to engage in various pharmacists' activities. [25, 26] The phenomenology approach which focuses on the understanding of pharmacists' subjective experiences was chosen as the methodological orientation to underpin the present study. This premise was considered apt due the descriptive nature of this research. [27] 
Community pharmacists
Community pharmacists who were working in Bangkok, Thailand were purposively sampled. Pharmacists were included if they were registered pharmacists working in any type of community pharmacy that supplies the HDS, and were able to communicate in the English language. Excluded were those who only performed administrative or procurement duties without any interaction with the customers. Initially, five pharmacists who were the key persons in community pharmacy practice in Bangkok, Thailand were recommended from the researchers' professional network. The subsequent informants were recruited using the snowball technique. Additionally, the maximum variation sampling was employed to ensure the informants were diversified in terms of characteristics (e.g., gender, years of working experiences, and employment status). The number of informants was finalised when the answers to all queries were saturated with no new or valuable information emerged from the interviews. Of all the pharmacists contacted, only two refused to be interviewed due to other commitments.
Study tool
For the semi-structured interviews, an interview guide was developed based on the extended TPB framework ( Table 1) . The face validity of the guide was checked by four experts in PCare from Chulalongkorn University and one experienced community pharmacist. It was then piloted among four registered community pharmacists. The questions were then amended accordingly to improve the clarity.
Data collection
The eligible pharmacists were contacted via telephone to arrange for the time and place of interview. All informants had no previous relationship with the authors. The interviews took place either at the investigators' site or at the informants' workplaces. Prior to each session, the informants were briefed about the study, and completed a written consent form. MSAW, a male researcher who is also a pharmacist, performed all interviews in English, using the interview guide described earlier to reduce interviewer bias by maintaining the consistency in the flow and technique of interview. The use of interpreter was not necessary since all of the informants were fluent in English. To minimise the possibility of influencing the way the informants responded to questions, the interviewer simply introduced himself as a researcher. Probing questions were used to clarify the meaning of the informants' responses. Each of the interview was audio-recorded, and field notes were taken. An interview session lasted approximately 1 h. At the end of the interviews, all informants were debriefed, and requested to fill out a short questionnaire to record their demographic details. No repeat interviews were required. As the primary researcher, MSAW has received the necessary training to conduct a qualitative research, and had previously involved in multiple research projects related to the HDS. 
Data analysis
All audio files were given identification codes to maintain the informants' confidentiality, and were then transcribed by one of the researchers. The accuracy of the transcription was confirmed by a co-researcher. The data were entered into ATLAS.ti version 7.5.17 (GmbH, Berlin, Germany), and were analysed line-by-line using qualitative content analysis (QCA). Using the QCA, data that were relevant to the research questions, were organised and grouped together under an appropriate category based on the extended TPB framework described earlier. [28] The QCA was conducted by the primary author. Check coding (peer audit) was employed to promote rigor by comparing the primary authors' interpretations with those of the other researchers. [29] The research team convened in multiple meetings to discuss data coding, categorisation, and interpretations, thereby ensuring the credibility and confirm-ability of the findings.
Results
A total of 22 community pharmacists were interviewed. Saturation of answers was achieved after the 20th interview. Additional two interviews, one with a male and another with a female pharmacist, confirmed data saturation. As demonstrated in Table 2 , 59.1% (13/22) of the informants were female. The mean age of the informants was 32 years old (range: 24-65 years). The average working years at the pharmacy was 4.32 years (range: 1-33 years). Half of the informants were working in independent community pharmacies, and the rest were employed by chain community pharmacies. About two-thirds of them (14/22, 63.6%) were full-timers. For their pharmacies, the approximate daily number of customers ranged from 20 to 1300 persons. According to their estimation, out of 10 customers, one to eight persons would request for HDS. When asked to approximate their provision of PCare based on 10 HDS users, only two pharmacists asserted they were able to deliver PCare for all 10 users. About 40% (9/22) of the informants estimated that they were able to provide PCare only to five or fewer people out of 10 HDS users. The main themes of behavioural understanding, and the underlying beliefs or factors influencing the provision of PCare for HDS users are summarised in Table 3 . Although the pharmacists were diverse in characteristics, the understanding of PCare for HDS users, and the underlying beliefs and factors for its provision were generally congruent.
Understanding of pharmacist care for herbal and dietary supplement users
The pharmacists expressed their views on what constitutes 'PCare for HDS users'. Six main themes were extracted for the pertinent activities. Giving advice or counselling on HDS use was the most common activity reported by the pharmacists. The advice was focused on the instruction for HDS consumption, importance of adherence to prescribed medication, and common side effects of HDS. Second to the advice was Gathering relevant information from HDS users. In this regard, the informants mentioned that they collected information such as the purpose of HDS use, medical conditions, and existing medicines from the HDS users. This information allowed them to assess the appropriateness of HDS use, and assisted them in the identification of HDSrelated problems. One informant stated:
Some customers have chronic diseases. . . Some are on warfarin that has many interactions. I ask "Do you use any medicine at the moment?" Important question to prevent interactions. (CP08)
Making a professional decision or suggestion for HDS use was identified as a crucial PCare activity for HDS users.
The pharmacists mentioned that they should be able to make a professional decision to recommend (or not recommend) the HDS consumption. Nonetheless, they reported that some customers insisted on taking HDS products, albeit for no particular importance or having limited evidence for the effectiveness. Unless major safety issues existed, the pharmacists usually complied with the customers' decisions to use the HDS. However, if the HDS was found to be harmful to the users, the pharmacists normally asserted their stance on discouraging the consumption.
Performing thorough assessment of HDS use, especially for the indication and safety issues, was another activity emphasised by nearly half of the informants. They pointed out that the HDS intake by their customers can be unreasonable. One pharmacist said: PCare
Sometimes they use (it) for the wrong indication. I have some cases where patients use fish oil for diabetes, and their blood glucose levels went out of control. (CP16) Accordingly, the informants emphasised their roles in evaluating whether the requested HDS meets their customers' health needs. Regarding the safety issues of HDS, many of the pharmacists revealed that they often checked for drug-HDS interactions but to a lesser extent for disease-HDS interactions and potential adverse effects.
Providing sufficient information for assisting customers' decisions was also an important part of PCare for HDS users. The informants believed that they should offer sufficient and unbiased information to customers in order to assist them making informed decision about HDS use. This activity is important to ensure customers' understanding of the benefits and limitations of HDS consumption in advance:
We have to give the exact information to the customers so that they can decide whether to use or not to use the supplements. (CP06)
Fostering pharmacist-customer relationship was another theme identified. The pharmacists opined the importance of listening attentively to customers' inquiries or request for the HDS. Most of them indicated that pharmacists in general should be aware that many people prefer to take the HDS and thus the matter should be discussed in an open and nonjudgmental manner.
Underlying beliefs and factors influencing pharmacist care for herbal and dietary supplement users
Behavioural, normative, control and professional normative beliefs about the provision of PCare for HDS users were elicited from the pharmacists. Regarding the behavioural beliefs, the informants reported that PCare benefited not only the HDS users but also their community pharmacies and themselves. The most mentioned PCare advantages were ensuring rational use of HDS (16/22) , and ensuring safety of HDS users (14/22). The pharmacists believed that they could promote rational use of the products by making sure the users received the type of HDS that is appropriate to their needs, in a suitable dose, for an adequate period of time, and at the lowest cost. One pharmacist stated:
The customers can use the best product. . . suitable for their symptoms and their budget. (CP07)
In the case of safety, the pharmacists affirmed that it could be assured through the prevention of HDS-drug interactions, overdosing, and adverse effects. Some pharmacists mentioned that PCare may prevent inappropriate HDS use particularly in pregnancy, and by patients diagnosed with kidney or hepatic problems.
Regarding the benefits for pharmacists, informants admitted that PCare could help them gain new knowledge about the HDS (8/22) especially when the users shared their experiences about a particular HDS. The informants also mentioned that the inquiries they received about the HDS products while providing PCare often led them to search for more information. Other advantages for the pharmacists included allowing them to appear more trustworthy (5/22), and providing them with self-satisfaction (5/22).
Concerning community pharmacies, the pharmacists believed that PCare promotes customer loyalty (9/22). A small proportion of the pharmacists believed that PCare could attract more customers (2/22), and enhance the image of their community pharmacies (2/22). One informant mentioned:
My drugstore only opens in the evening with short opening hours, but my customers wait for me. They like to consult me. They will tell (their) friends and family about my service, and I will get more customers. (CP05) Given all the aforementioned benefits, one pharmacist mentioned that PCare for HDS users can be time-consuming:
Customers spend 30 minutes with me. Some people spend about one hour with me, they have many questions. (CP08)
With respect to the normative beliefs, the informants felt encouraged to provide PCare for HDS users by individuals such as the HDS users themselves (13/22), and their colleagues (4/22). Very few mentioned that they were motivated by other external entities such as the doctors, and governmental organisations. They mostly agreed that no entity disapprove the provision of PCare for HDS users. One pharmacist however, mentioned that her efforts to provide PCare for some HDS users were discouraged by the users' family members.
As for the control beliefs, numerous factors that were either the facilitators or barriers to the provision of PCare for HDS users were uncovered. These factors were generally customer-, pharmacist-or community pharmacyrelated. Regarding the facilitators, the most commonly cited customer-related factor was the conversation on HDS initiated by the HDS users themselves (e.g., by asking recommendation for a HDS product) (15/22) . Some informants mentioned that the type of HDS users who expressed trusts in them (5/22) , and the willingness of HDS users to spend time discussing with pharmacists (4/ 22), were the motivating factors for the provision of PCare for HDS users.
Several informants (6/22) mentioned certain characteristics of the HDS users whom they regarded as the facilitating factors for the provision of PCare. The HDS users who they perceived as easier to be provided with PCare included those who have high education and middle to high incomes, and who were health professionals. To some pharmacists, HDS users of the younger age group are easier to be provided with PCare, whereas to some others, the middle-aged and older adults were easier.
Many pharmacists identified professional training as an indispensable facilitating factor (11/22) for the provision of PCare for HDS users. Such training would keep them updated with the current HDS information, and make them more confident in dealing with the HDS users. One pharmacist noted:
The company provides training for us every month where we learn new HDS products in the market. We learn how to provide proper care. (CP01) Additionally, many pharmacists (11/22) mentioned that they are the expert in PCare for HDS users because they own an integrated knowledge in pharmaceutical products, human diseases, and the HDS. Several pharmacists also asserted that they were more knowledgeable in the area compared to other healthcare professionals:
We provide care for them because we know about the HDS. . . I think pharmacists know the best. (CP15) Many pharmacists believed that the availability of reference materials about the HDS (e.g., leaflets, posters, booklets, etc.) (14/22) could assist them in providing PCare for HDS users. Many pharmacists also mentioned that the access to Internet (10/22) , and access to scientific evidences for HDS (7/22) at their community pharmacies were important.
According to the informants, one major barrier to PCare delivery is customers' reluctance to accept pharmacists' opinions about the HDS (14/22) . This scenario usually occurred with assertive customers or with those who believe that they were knowledgeable about the HDS. Another problem encountered was customers' unwillingness to communicate with pharmacists (12/22) . The pharmacists noted:
They have some "walls" to receive any information because they think they know the best. . . They don't listen to the pharmacists. (CP19) Some patients just pick up, and don't want any advice. They just come and buy, and go. (CP05)
Additionally several pharmacists (8/22) mentioned certain characteristics of the HDS users as barriers for the provision of PCare. The HDS users who were perceived as uneducated, and who were office workers and foreigners (non-Thais), were viewed as difficult to be provided with PCare.
Some pharmacists mentioned busyness as a hindrance factor (6/22) . In this regard, the pharmacists submitted that they were under pressure to execute multiple roles at their pharmacies during busy hours, resulting in inefficient provision of PCare for HDS users. One pharmacist mentioned:
Sometimes we have five people come at the same time, and we cannot provide advice for all. They lined up so we just can't. (CP20)
Other barriers included the insufficient coverage of HDS topics in their previous undergraduate pharmacy programs (5/22) , and their limited knowledge in HDS (5/22):
We learned for five years. Although we learned pharmacognosy, that's all, it's just one subject. (CP11) I sometimes don't know everything about the HDS.
Some barriers to the provision of PCare for HDS users were associated with the settings of the community pharmacies. These barriers included the limited source of information in the community pharmacies (5/22), limited access to scientific evidences for HDS (3/22) , and restrictive space to conduct PCare activities (1/22) .
In regard to the professional normative beliefs, many informants believed that PCare was part of a pharmacist's job descriptions (12/22) , and as a healthcare professional, they have roles and responsibilities distinguishable from other non-professionals e.g., salespersons/cashiers (9/22). One informant articulated her view:
We are pharmacists, and not just sellers. . . You can't just come, and get what you want, and go out. Otherwise, we are not different from the cashiers. (CP11)
Discussion
The pharmacist informants had a certain understanding of PCare for HDS users, and considered the activities such as fostering relationship with the HDS users, collecting HDS users' information, assessing their needs for HDS, providing sufficient information, and giving appropriate advice as important. The pharmacists readily associated the provision of PCare to a more rational and safer use of HDS, and advantageous for them personally, and for their community pharmacies. Despite the effort to provide PCare for HDS users, similar to findings from the previous studies, the informants would let the customers to have the final decision on whether to take the HDS. [9, 30] Nevertheless, if the HDS products were found to be potentially harmful, i.e., causing adverse effects, or drug-and disease-interactions, the pharmacists would take a paternalistic approach [31] by discouraging its use. It is worth noting that most pharmacists did not clearly touch upon some PCare activities that are considered important in the pharmaceutical care processes recommended by Cipolle et al., [21] such as performing the follow-up evaluations and documentation of customers' HDS use, providing evidence that pharmaceutical care practices are not being fully implemented in Thai community pharmacies.
The HDS users were perceived as the most significant individuals who pressured pharmacists into providing PCare. However, the behaviours and attitudes of the users may influence pharmacists to provide PCare for them. In keeping with previous studies, [30, 32] pharmacists in the present study were more likely to be reactive rather than proactive in providing PCare. As such, they tended to offer PCare to those who initiated conversation about the HDS. On the contrary, many pharmacists were hesitant to provide PCare to HDS users who they described as assertive and aggressive. These HDS users, who are frequently described as the 'new consumers' or 'lay experts', [33] commonly challenged their knowledge, and refused to recognise their professional opinions. Additionally, the pharmacists also mentioned that they often encounter the HDS users who just come to 'pick and purchase' some HDS products, and avoid any advice. The pharmacists were reluctant to engage with these HDS users possibly due to the fear that their unsolicited opinion may be rejected, or fearing that their intervention may leave a repercussion on their relationship with the users.
The 'assertive' HDS users and those who belonged in the 'pick-and-pay' category may possess a strong sense of self-perceived ability and confidence in deciding their own treatments or having a long-term devolution to a particular product. [34] Although it can be argued that these HDS users have experienced the outcomes that the products have left on their health, this experience is hardly adequate for them to understand the complexities of the effects of HDS, especially when consumed together with modern medicines. Additionally, since the information obtained by the HDS users normally are obtained from unreliable sources of information (e.g., Internet, family and friends), [2] the selfselection of HDS may be inaccurate.
In the absence of a mutual engagement among pharmacists and HDS users, problems associated with HDS use cannot be identified. [21] Therefore, pharmacists should be encouraged to listen and communicate to HDS users attentively even if they are adamant with their pre-existing knowledge and beliefs. [35] It is crucial for pharmacists to apprehend the HDS users' perspectives about the HDS, especially in regard to their desire and beliefs for HDS consumption. [13] There is also a need to find new ways of communication with HDS users, especially with those who decline unsolicited advice.
The present study showed that the pharmacists categorised HDS users as easy or difficult to provide PCare according to their personal characteristics. It was noted that the pharmacists who were younger and less experienced tend to stereotype customers as easier or more difficult to be provided with PCare. It is possible that these pharmacists would only want to engage with the HDS users whom they perceived as receptive to PCare, thus avoiding those who are more challenging to deal with. Nevertheless, there is a concern that those who were negatively stereotyped may actually be the ones who need PCare.
Several previous surveys [36] [37] [38] indicated that pharmacists believed that their knowledge of HDS is inadequate -a notion shared by only a few pharmacists in the present study. Half of them actually regarded themselves as the expert in caring for the HDS users. This is certainly a good sign as self-efficacy is a key predictor for the performance of behaviour. The pharmacists who were younger than 30 years old and those having <5 years of experience in their community pharmacies appeared to be more confident and interested in offering PCare for HDS users. These young pharmacists may be more receptive to the 'pharmaceutical care provider' role of pharmacists or may be more cognisant of the current trend of HDS consumption and the variety of HDS products in the market. Nevertheless, although many of the pharmacists regarded themselves as the expert in caring for HDS users, many of them still recognised the continuing professional training related to HDS as important, warranting the provision of such training on a regular basis.
Information resources for HDS were construed as necessary to support the provision of PCare for HDS users. It is worth noting however, that most of the reference materials that pharmacists often referred to (e.g., leaflets and posters) were supplied by the HDS manufacturers. These materials can be highly promotional in nature, and may be incomplete. A survey by Raynor et al., [39] confirmed that many leaflets of herbal medicine products in the UK do not include key safety information, such as precautions and side effects. Pharmacists should therefore be vigilant of the reference materials that can be misleading and incomplete. In addition, most pharmacists also cited the access to Internet as a facilitating factor as it serves a means to get immediate information in a busy working environment. As such, pharmacists should be made aware of the unreliable information in the Internet. Training for pharmacists to appraise HDS information obtained from the Internet should be warranted.
It should be noted that several facilitators mentioned by the pharmacists such as the continuing education in HDS, reference materials about HDS, and the access to Internet can be highly dependent on the management of community pharmacies to provide. Nonetheless, none of the pharmacists in the present study regarded their managers as the individuals who motivated them to provide PCare for HDS users, indicating that such service was not a priority from the management's perspective. Therefore in effort to optimise the provision of PCare for HDS users, the managers of community pharmacies should also be targeted by making them aware of the benefits of the service and the requirement needed by their pharmacists to provide such care.
In a previous study, Culverhouse and Wohlmuth [40] noted that the cost of HDS appeared to be a factor that influenced the recommendation of the products by Australian pharmacists. The study showed that pharmacists would recommend cheaper products to provide value to their customers. Similarly, Kanjanarach et al., [9] found that cheaper HDS products were more likely to be suggested by Thai community pharmacists. On the other hand, findings from the present study showed that the cost of HDS was neither a facilitator nor a barrier for the provision of PCare for HDS users. This implies that in the absence of other barriers, pharmacists would provide PCare for HDS users regardless of the price of the products. In addition, it should also be noted that it is common for HDS companies to provide profit incentives to community pharmacists to sell their products. However, the findings from the present study showed that profit incentives did not emerge as an important influencing factor for the provision of PCare for HDS users. This finding was similar to that from an Australian study that showed the decision to sell HDS products by community pharmacists was not influenced by profit incentives. [41] The professional norm emerged as a pronounced factor for the PCare delivery. This result is similar to the previous studies that suggested many pharmacists reacted positively to their role in ensuring the safe use of HDS. [13, 30] This norm is in fact not part of the original TPB framework. However, in the Triandis' theory of interpersonal behaviour, the professional norm is considered as part of the personal normative construct which is a pivotal determinant of behavioural intention. [42] In a systematic review of the studies that predict healthcare professionals' intentions and behaviours based on social cognitive theories, the 'professional role/identity' was found to be a significant determinant in 8 out of 14 studies. [15] Therefore, in an effort to encourage pharmacists to be more proactive in providing PCare for HDS users, it is vital to emphasise their care responsibility for both drug therapy and the HDS.
Limitations of the study
This qualitative study was conducted only among community pharmacists working in Bangkok for ease of data collection. Their understanding about PCare for HDS users and the underlying beliefs and factors for its provision may be different from pharmacists in the other regions of the country. In addition, all interviews were conducted in English, and therefore there might be a risk of miscommunication between the interviewer and the informants. However, due to quality referrals, all of the informants were fluent in English, and did not require the aid of an interpreter. Additionally, since the pharmacists were interviewed about their engagement in PCare activities, their responses may be subjected to social desirability bias despite being offered with anonymity and confidentiality. It should be pointed out however, that the total sample of the pharmacists also included those who admitted that they were not proactive in engaging in some PCare activities related to the HDS, providing evidence that the social desirability bias was in a way reduced. Furthermore, this study could not determine the extent to which the identified underlying beliefs and factors were correlated with the pharmacists' intentions to provide PCare for HDS users and its actual implementation. A quantitative survey with a specially designed questionnaire would be more appropriate for that purpose.
Conclusion
The study explored the understanding of community pharmacists about PCare for HDS users, and identified various underlying beliefs and factors influencing its provision. The pharmacists interviewed, acknowledged the benefits of providing PCare for HDS users, but its implementation was mostly conditional to many facilitators and barriers related to the customers, pharmacists, and the community pharmacies. The findings obtained from this study can serve as an input to inform several strategies to promote the provision of PCare for HDS users, such as the offering of training programs to enhance confidence among the pharmacists, conducting campaigns to encourage pharmacists to provide PCare for HDS users, and equipping reliable information resources in the community pharmacies. Moreover, the identification of factors based on the TPB may facilitate the design of a survey questionnaire that can be used in a large, representative sample of pharmacists to quantitatively measure and statistically assess the strengths of the identified beliefs and factors on their intention to provide PCare for HDS users and its actual implementation.
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